Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Executive Vice President and Chief Technology Officer
-
Stock Symbol
-
MCRB on Nasdaq
David S. Ege - trading volume in the past year for Seres Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
77.6K |
$65.2K |
$0.84 |
Aug 16, 2024 |
Direct |
|
|
| Restricted Stock Units |
29.7K |
$32.2K |
$1.08 |
Aug 15, 2024 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
288K |
|
|
Feb 14, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.